The limited specificity of histological examination in the diagnosis of dysplastic nevi
- PMID: 18976415
- DOI: 10.1111/j.1600-0560.2008.01131.x
The limited specificity of histological examination in the diagnosis of dysplastic nevi
Abstract
Dysplastic nevi were originally described as a distinct entity with specific clinical and histological features of importance as direct precursors of malignant melanoma and as markers of patients at increased risk of developing melanoma in the setting of familial melanoma. Nevi with the clinical and histological features described first as 'B-K moles' and later as 'dysplastic nevi' clearly do exist and do sometimes represent melanoma precursors or melanoma risk markers, but it is now recognized that most dysplastic nevi never progress to melanoma, that the histological features originally described in nevi in familial melanoma patients are poorly correlated with dysplastic nevi as they are defined clinically, and that overlapping or identical histological features are found in a variety of other melanocytic lesions including small (< 5 mm) melanocytic nevi, lentiginous nevi, atypical (dysplastic) lentiginous nevi, lentiginous melanoma, lentigo maligna and nevi in an ever-growing number of 'special sites'. This article will briefly review the evolution of our understanding of the histological range of nevi and the histological differential diagnosis of dysplastic nevi.
Similar articles
-
[Dysplastic melanocytic nevus].Duodecim. 2010;126(21):2492-501. Duodecim. 2010. PMID: 21171474 Review. Finnish.
-
Dermatoscopy of "dysplastic nevi": a beacon in diagnostic darkness.Eur J Dermatol. 2006 Sep-Oct;16(5):479-93. Eur J Dermatol. 2006. PMID: 17101467 Review.
-
Dysplastic nevi and malignant melanoma.Am Fam Physician. 1990 Aug;42(2):372-85. Am Fam Physician. 1990. PMID: 2200246 Review.
-
[Focal melanocytic atypia in dysplastic nevus cell nevi. Results of a serial section study].Hautarzt. 1989 Nov;40(11):701-7. Hautarzt. 1989. PMID: 2606669 German.
-
Dysplastic nevi and the dysplastic nevus syndrome.Dermatol Clin. 1992 Jan;10(1):189-201. Dermatol Clin. 1992. PMID: 1730167
Cited by
-
Novel multiple markers to distinguish melanoma from dysplastic nevi.PLoS One. 2012;7(9):e45037. doi: 10.1371/journal.pone.0045037. Epub 2012 Sep 27. PLoS One. 2012. PMID: 23028750 Free PMC article.
-
Management of melanoma families.Cancers (Basel). 2010 Apr 16;2(2):549-66. doi: 10.3390/cancers2020549. Cancers (Basel). 2010. PMID: 24281082 Free PMC article.
-
Cell cycle analysis can differentiate thin melanomas from dysplastic nevi and reveals accelerated replication in thick melanomas.Virchows Arch. 2014 May;464(5):603-12. doi: 10.1007/s00428-014-1570-1. Epub 2014 Mar 30. Virchows Arch. 2014. PMID: 24682564
-
The texture of collagen and immunoexpression of PRAME in dysplastic nevus syndrome lesions: relationship with melanoma.An Bras Dermatol. 2023 Jan-Feb;98(1):128-130. doi: 10.1016/j.abd.2022.02.002. Epub 2022 Nov 8. An Bras Dermatol. 2023. PMID: 36369201 Free PMC article. No abstract available.
-
HLA antigen expression in melanocytic lesions: is acquisition of HLA antigen expression a biomarker of atypical (dysplastic) melanocytes?J Am Acad Dermatol. 2012 Jun;66(6):911-6, 916.e1-8. doi: 10.1016/j.jaad.2011.04.025. Epub 2012 Mar 23. J Am Acad Dermatol. 2012. PMID: 22445792 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources